Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-01-17
1986-10-14
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, C07D27734, A61K 31425
Patent
active
046173129
ABSTRACT:
A series of 5-(2-alkoxyphenyl)thiazolidinediones and pharmaceutically acceptable salts thereof useful as hypoglycemic agents, aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications; intermediates therefore; and process for preparation of said compounds.
REFERENCES:
Sohda et al., Chem. Pharm. Bull. 30, 3601-3616 (1982).
Gerstl Robert
Knuth Charles J.
Pfizer Inc.
Richardson Peter C.
Sheyka Robert F.
LandOfFree
Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinedione does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinedione, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinedione will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1340534